Regular supraventricular tachycardias associated with idiopathic atrial fibrillation

The present study analyzed the recurrence rate of idiopathic atrial fibrillation (AF) after elimination by radiofrequency ablation of the substrate for a regular tachycardia. Forty consecutive patients with idiopathic AF and a history of regular palpitations or documented regular tachyarrhythmias were prospectively included. Regular tachyarrhythmias were induced in 82.5% of patients: atrial flutter (42.4% of the inducible arrhythmias), atrial tachycardia (24.2%), atrioventricular (AV) nodal reentry (18.2%), AV reentry through a concealed accessory pathway (9.1%), and AV nodal reentry associated with right atrial tachycardia (6.1%). Dual AV node physiology with single or dual AV node echoes was demonstrated in 6.1% of patients without inducible arrhythmias. During follow-up (92 +/- 11 months), AF recurred in 19.2% of patients after successful radiofrequency ablation and in 69.2% after unsuccessful or not performed procedures (p <0.05). Left atrial diameter did not change after successful ablation but increased significantly in the population without elimination of the substrate (initial diameter 37.5 +/- 2 mm, final diameter 46.4 +/- 3.2 mm; p <0.05). In conclusion, the systematic search for the substrate of regular tachyarrhythmias followed by their elimination by catheter ablation reduces the recurrence of idiopathic AF in patients with a history of regular palpitations or documented regular tachyarrhythmias.     

射频导管消融360例儿童心律失常的疗效和安全性

目的 评价射频导管消融360例儿童心律失常的疗效和安全性。方法 回顾性分析2000年1月2013年12月360例因心律失常在我院接受射频导管消融的儿童患者360(男213例、女147)例,年龄15个月14(10±3)岁,平均体质量34 kg。结果 急性期消融成功率98.9%(356/360例),4例消融失败。360例患者中,阵发性室上性心动过速308例,占85.6%,307例(99.7%)患者消融成功,其中隐匿性房室旁路伴房室折返性心动过速121例、显性旁路(预激综合征)82例、房室结折返性心动过速105例;室性心律失常42例,其中室性早搏15例(均消融成功),27例室性心动过速(其中4例并发结构性心脏病,25例消融成功);房性心律失常10例(9例消融成功,其中典型心房扑动3例,不典型心房扑动1例,局灶性房性心动过速6例)。所有患儿围术期均未出现明重要并发症。术后随访至少12个月,随访期复发率为2.2%(8/356例),其中6例经再次消融成功。结论 射频导管消融术治疗有适应证的心律失常儿童安全有效。     

Role of Radiofrequency Ablation in the Management of Supraventricular Arrhythmias:

Radiofrequency Ablation of Supraventricular Arrhythmias, Introduction: Several reports iiave demonstrated that radiofrequency catheter ablation provides effective control of a variety of supraventricular tachycardias. However, the efficacy, complications, risk of arrhythmia recurrence, and follou-up survival analysis have not been reported in a large series of consecutive patients with supraventricular arrhythmias with diverse electrophysiologic mechanisms. This report details the results of radiofrequency catheter ahiation in 760 consecutive patients (386 males, 374 females) with a wide variety of supraventricular tachycardias treated at one center. Methods and Results: Arrhythmias were associated with the presence of an accessory pathway i n 363 patients (384 accessory pathways), including four patients with Mahaim fibers and eight patients with the permanent form of junctional reciprocating tachycardia. The mechanism of the clinical arrhythmia was AV nodal reentrant tachycardia in 245 patients, and a primary atrial tachycardia in 20 patients (ectopic atrial tachycardia in 16 patients and sinus nodal reentry in 4 patients). Ablation of the reentrant circuit of atrial flutter within the right atrium was attempted i n 13 patients. AV node ahiation and permanent pacemaker implantation were performed in 119 patients with medically refractory atrial fihrillation or flutter. Radiofrequency catheter ahiation was successful in 346 of 363 patients (95.3%, CI 93.I%–97.5%) with accessory pathways (367 of 384 pathways, 95.6%, CI 93.5%–97.6%) with a complication rate of 1.1% and a recurrence rate of 5.5%. Successful accessory pathway ablation was achieved for 179 of the first 192 pathways treated (93.2%, CI 89.7%–96.6%) and increased to 188 of 192 pathways (97.9%, CI 95.9%–99.9%) over the second half of the series. AV nodal reentry was successfully abolished in 244 of 245 patients (99.6%, CI 98.8%–100%) by selective ablation of the slow pathway in 234 patients and the fast pathway in 10 patients. The complication rate in this group was 2.0% with a recurrence rate of 6.5%. All 20 primary atrial tachycardias were successfully ablated with no complications and a recurrence rate of 15%. The reentrant circuit of atrial flutter was ahlated successfully in 10 of 13 patients (77%) with recurrent atrial flutter in one additional patienl. Complete AV block was achieved in 117 of 119 (98.3%, CI 96.0%–100%) patients with atrial fibrillation or flutter treated hy AV nodal ablation with a complication rate of 0.8% and recurrence of AV conduction in 6%. The median duration of fluoroscopy exposure for the population was 23.4 minutes. The overall primary success rate for the entire population was 97.0% (737 of 760 patients, CI 95.8%–98.2%). Conclusion: Thus, the results of this large series of patients demonstrates the safety and efiicacy of radiofrequency ahiation for the treatment of a wide variety of supraventricular arrhythmias. It also appears that increasing experience with these procedures increases the rate of successful ahlation and decreases the risk of complications.     

Catheter Ablation with Radiofrequency Energy: Biophysical Aspects and Clinical Applications

Radiofrequency Catheter Ablation. Radiofrequency catheter ablation techniques are becoming increasingly accepted as the therapy of choice for selected patients with symptomatic arrhythmias. The ability to titrate the power output using radiofrequency current has allowed these ablative techniques to be applied safely in a variety of arrhythmias. In many institutions, radiofrequency catheter ablation has now become standard therapy for controlling medically refractory atrial arrhythmias using atrioventricular (AV) junction ablation and for curing AV nodal reentrant tachycardia and supra ventricular tachycardia due to accessory AV connections. This technology is also being used to treat some forms of ventricular tachycardia such as bundle branch reentry ventricular tachycardia, ventricular tachycardia in structurally normal hearts, and with limited success in patients with ventricular tachycardia and coronary artery disease. Advancements in catheter design and energy delivery systems may further expand the use of this form of therapy. (J Cardiovasc Electrophysiol, Vol. 3, pp. 173–186, April 1992)     

Follow-up of radiofrequency catheter ablation in children: Results in 100 consecutive patients

Objectives. The purpose of this study was to determine the outcome of a group of closely followed-up pediatric patients who had undergone radiofrequency ablation for cardiac arrhythmias.Background. Although radiofrequency ablation in children has been shows to be effective and safe in the short term, results of longer term follow-up of these children must he considered when determining the place of radiofrequency ablation in the management of pediatric arrhythmias.Methods. One hundred children aged 2 months to 17 years underwent a total of 119 radiofrequency ablation procedures for cure of tachycardia. Follow-up clinical data, electrocardiograms and 24-h Holter monitors were obtained and analyzed.Results. All patients were alive, and none were lost to follow-up after a mean follow-up of 21.5 months (range 6 to 50). Success at last follow-up included accessory pathways in 66 (89%) of 74 patients, atrioventricular (AV) node reentry in 15 (88%) of 17, intraatrial reentry in 2 (67%) of 3, atrial flutter in 3 (100%) of 3, atrial ectopic tachycardia in 2 (67%) of 3, junctional ectopic tachycardia in 1 (100%) of 1 and ventricular tachycardia in 2 (100%) of 2 (overall success, 90 [90%] of 100). All recurrences were observed within 6 months of ablation. Major and minor complicatons (7%) included chest burn (one patient), foot microembolus (two patients), hematoma without pulse loss (four patients), femoral arteriovenous fistula requiring repair (one patient) and transient Mobitz I AV block (one patient). Immediate success, recurrence and complication rates were similar in the ≥12-year old versus the < 12-year old group. Echocardiograms, available in 109 (92%) of 119 patients, showed possible procedure-related abnormalities in 2 (mitral regurgitation in 1, tricuspid regurgitation in 1, both mild), with no aortic insufficiency after 30 left-sided ablations performed by the retrograde approach. Follow-up Holter monitors, available in 77 (77%) of 100 patients, showed possible procedurerelated abnormalities in 5 (frequent atrial ectopic tachycardia in 2, atrial flutter in 1, accelerated ventricular rhythm in 2). There were no early or late deaths.Conclusions. In children, the risks of radiofrequency ablation are low at follow-up evaluation. Longer-term follow-up of children undergoing radiofrequency ablation will be necessary to determine whether coronary abnormalities or serious new arrhythmias will develop.     

Dependence of electrogram duration in right posteroseptal atrium and atrium-pulmonary vein junction on pacing site: mechanism and implications regarding atrioventricular nodal reentrant tachycardia and paroxysmal atrial fibrillation

INTRODUCTION: The fractionated atrial electrogram, a signal helpful in identifying the target site for radiofrequency catheter ablation of the slow AV nodal pathway, is considered to arise from nonuniform anisotropic electrical activity. However, the effects of pacing sites and radiofrequency ablation on these electrograms are not clear. Similarly, the nature of the fractionated atrial electrogram in the atrium-pulmonary vein junction has yet to be determined. METHODS AND RESULTS: Two experiments were performed in this study. Experiment 1 evaluated the fractionated atrial electrogram at target sites before and after slow AV nodal pathway ablation during sinus rhythm or during pacing from different sites. Group 1A consisted of 16 patients with dual AV nodal pathway physiology and AV nodal reentrant tachycardia who underwent successful ablation without residual slow AV nodal pathway. Group 1B consisted of 7 patients who underwent successful elimination of AV nodal reentry but with residual dual AV nodal pathway physiology. Group 1C consisted of 6 patients who still had AV nodal reentrant tachycardia after two applications of radiofrequency energy. In group 1D, there were 16 patients with dual AV nodal pathway physiology, but without inducible AV nodal reentrant tachycardia. In group 1E, there were 15 patients without dual AV nodal pathway physiology. Experiment 2 investigated the fractionated atrial electrogram in the ostium of the left and right superior pulmonary veins in 18 patients with paroxysmal atrial fibrillation (2A) and in 8 patients without paroxysmal atrial fibrillation (2B). Before radiofrequency ablation, electrogram duration in the right posteroseptal atrium during pacing from the middle coronary sinus or the right posterolateral atrium was shorter than that during pacing from the high right atrium (HRA) in all group 1 patients. After the successful elimination of the slow AV nodal pathway conduction in group 1A, atrial electrogram duration during HRA pacing was shorter than that before ablation. In experiment 2 patients, electrogram duration during pacing from the proximal or distal coronary sinus was shorter than that during pacing from HRA or sinus rhythm. CONCLUSION: These findings suggest that the fractionated atrial electrograms in the right posteroseptal atrium and ostium of left or right superior pulmonary veins are potentially consistent with nonuniform anisotropic propagation. Alternations of electrogram characteristics after successful radiofrequency ablation of the slow AV nodal pathway may arise from the changes of nonuniform anisotropic activity in the right posteroseptal atrium.     

Tachycardia-induced tachycardia: definitive treatment with radiofrequency ablation. Presentation of three cases]

Tachycardia-induced tachycardia is the phenomenon in which one tachycardia degenerates into another. Few data are available in patients suffering from AV nodal reentrant tachycardia an atrial fibrillation. For related to AV nodal reentrant triggered by tachycardia; there is a possible effective treatment by eliminating the slow nodal pathway, with radiofrequency ablation, as shown by other authors. In this study we present data on three patients with repeated episodes of documented atrial fibrillation and at least one episode of AV nodal reentrant tachycardia or regular palpitations. Radiofrequency ablation of the slow AV nodal pathway was successfully performed in both, and at a follow up of 6, 9 and 10 months, respectively, no new episode of AV nodal reentrant tachycardia or atrial fibrillation was documented.     

Radiofrequency Current Catheter Ablation for Control of Supraventricular Arrhythmias

Radiofrequency Catheter Ablation in SVT. With the advent of radiofrequency energy, catheter ablation techniques have become an accepted form of treatment for a variety of Supraventricular arrhythmias. The ablation of the atrioventricular (AV) node was performed first and is now widely used in patients with refractory atrial fibrillation or flutter. Ablation has also replaced surgery in patients with preexcitation syndromes, and as the complication rate in experienced centers is low, it has become the first line of treatment in these institutions. The results of catheter ablation in AV nodal reentrant tachycardia are excellent as well, although there is still debate about whether "slow" pathway ablation is superior to "fast" pathway ablation. Radiofrequency current ablation has also contributed to a better understanding of the pathophysiology of AV nodal reentrant tachycardia, as it has provided evidence for atrial participation in the reentrant circuit. Experience with atrial tachycardias and tachycardias due to Mahaim fibers remains limited. The ideal source of energy for specific arrhythmias is still unknown and improvement in catheter technology is needed.     

Experience in 1,500 patients undergoing radiofrequency ablation in the treatment of tachycardias

Several reports have demonstrated that radiofrequency catheter ablation provides effective control of a variety of supraventricular and ventricular tachycardias. This report details the results of radiofrequency catheter ablation in 1500 consecutive patients with a wide variety of supraventricular and ventricular tachycardias treated in the Instituto Nacional de Cardiología "Ignacio Chavez", between April 22, 1992 until December of 1999. Tachycardias were associated with the presence of an accessory pathway in 987 patients (65.8%). Dual accessory pathways were present in 24 patients giving a total of 1,012 accessory pathways. The mechanism of the arrhythmia was atrioventricular nodal reentrant tachycardia in 321 patients (21.4%). Ablation of the reentrant circuit of atrial flutter within the right atrium was attempted in 109 (7.2%) patients and a primary atrial tachycardia in 13 patients (0.8%). Atrioventricular node ablation and permanent pacemaker implantation were performed in 26 patients (1.7%). Finally we performed radiofrequency catheter ablation in 37 (2.4%) patients with ventricular tachycardia. Radiofrequency catheter ablation was successful in 908 of 1012 (89.7%) patients with accessory pathways with a complication rate of 10 (0.98%) and a recurrence rate of 92 (9%). AV nodal reentry was successfully abolished in 319 of 321 patients by selective ablation of the slow pathway in 297/321 (92.5%) patients and the fast pathway in 22/24 (92%) patients. The complication rate of this group was 8/321 (2.4%) with a recurrence rate of 34 patients (10.5%). The reentrant circuit of atrial flutter was ablated successfully in 86 of 109 (76.8%) patients with a recurrence flutter in 14 (12.8%) patients. Five of 13 (38.4%) cases of primary atrial tachycardia were successfully ablated. Complete AV block was achieved in 26 of 26 (100%) patients with atrial fibrillation or flutter treated by AV nodal ablation. The procedure was successful in 28 of 37 (75.6%) patients with fascicular ventricular tachycardia. The results of this series of patients demonstrates the safety and efficacy of radiofrequency ablation for the treatment of a wide variety of taquicardias with high rate of success 1375 of 1500 patients (91.6%), with 142 recurrences (9.4%), 15 complications (1%), and no mortality.     

New Horizons in Catheter Ablation

Catheter ablation has evolved into the dominant therapeutic modality in the treatment of a variety of arrhythmias, particularly supraventricular arrhythmias with the mechanisms of atrioventricular (AV) nodal reentry and AV reciprocating tachycardia via an accessory pathway. The mode of catheter ablation used in the great majority of cases is radiofrequency (RF) catheter ablation. This technology is well-suited for the above arrhythmias because the targets and the RF lesions are both small and discrete. Using temperature monitoring may improve the outcome of these procedures by decreasing procedure time and incidence of coagulum formation on the catheter after a sudden rise in electrical impedance. New RF catheter designs and new modalities of creating catheter-induced focal myocardial injury will allow operators to have improved success with the ablation of less approachable arrhythmias, including atrial flutter and reentrant ventricular tachycardia. Studies are currently underway to create a catheter based "maze" procedure for the treatment of atrial fibrillation. As techniques and technologies evolve, a greater proportion of patients with symptomatic or threatening arrhythmias may be approached with catheter ablation as a curative or palliative procedure.     

Catheter Ablation for the Treatment of Paroxysmal Supraventricular Tachycardia

Catheter Ablation for PSVT. Radiofrequency catheter ablation has evolved into a front-line curative therapy for patients who have paroxysmal supraventricular tachycardia secondary to Wolff-Parkinson-White syndrome, AV nodal reentrant tachycardia, and atrial tachycardia. In patients with accessory pathways, cure rates exceed 90% in almost all anatomic locations. Equally high success rates are noted in patients with atriofascicular pathways and the permanent form of junctional reciprocating tachycardia. Complications secondary to catheter ablation of accessory pathways occur in 1% to 3% of patients and include cardiac perforation, tamponade, AV block, and stroke. In patients with AV nodal reentrant tachycardia, selective slow pathway ablation is curative in over 95% of patients with a very low risk of AV block. Atrial tachycardias originating in both the left and right atria can he successfully ablated in over 80% of patients. Given the overall effectiveness of this procedure, radiofrequency catheter ablation should be considered as front-line therapy in patients with recurrent or drug-refractory paroxysmal supraventricular tachycardia. Although an effective therapy, the risks and benefits of this procedure need to be assessed in all patients who are candidates for this procedure.     

Paediatric radiofrequency ablation experience at a Venezuelan cardiology facility

Radiofrequency (RF) ablation is a curative treatment for many different types of cardiac arrhythmias but its application has been more limited in the paediatric population. We here describe RF paediatric ablation experience at a 400-bed University Hospital in a western Venezuelan province and compare it with the results reported in other countries. METHODS: One hundred and fifty five patients under 18 years of age who where submitted to RF ablation between 1994 and 2007 were included. The patients were 12.8+/-3.4 year-old (rank: 3-17 years); 59% were female. Nine patients were submitted to more than one procedure. AV nodal re-entrant tachycardia and atrio-ventricular re-entrant tachycardias mediated by accessory pathways made up 83% of the ablations. The overall success rate was 91.5%. In the AV nodal re-entrant tachycardia and atrial flutter, success rate almost reached 100%. Ablation was successful in 93% of the patients with the Wolff-Parkinson-White syndrome. The overall complication rate was 5% with 0.6% of major complications and 0% death rate. The results were comparable to those recently reported by the cooperative paediatric ablation registry in the United States of America and by a large hospital in Taiwan. CONCLUSION: RF ablation is a curative therapy with a high success rate and very low complication rates in the paediatric population at the Cardiovascular Research Institute of the University Hospital of The Andes in Venezuela.     

Atrioventricular nodal reentry tachycardia in children: curative treatment by high frequency catheter ablation

BACKGROUND: Atrioventricular nodal reentrant tachycardia (AVNRT) is one of the most common forms of supraventricular tachycardia in the pediatric population. PATIENTS AND METHODS: 41 children with a mean age of 9.6 (3.7-16) years with recurrent atrioventricular nodal reentrant tachycardia (AVNRT) refractory to medical treatment (n = 38) and recurrent syncope (n = 3) underwent electrophysiologic (EP) study. In all patients dual AV-nodal physiology could be demonstrated during EP study and typical form of AVNRT (mean heart rate 220/min) could be induced by programmed atrial stimulation. A steerable 7 F ablation catheter was placed at the inferoparaseptal region of the tricuspid valve annulus close to the orifice of the coronary sinus with the intention to record a late fractionated local atrial electrogram during sinus rhythm. Starting at this point radiofrequency current (500 kHz) with a target temperature of 70 degrees C was delivered with the intention to ablate the slow pathway. If a slowly accelerated junctional rhythm (< 120/min) occurred during energy discharge, programmed atrial stimulation was repeated. Otherwise radiofrequency current was delivered step by step up to a septal position next to the tricuspid valve annulus. Slow pathway ablation was defined as lack of evidence of dual AV nodal pathways during repeated atrial stimulation. Slow pathway modulation was defined as maximal one atrial echoimpulse after ablation. RESULTS: The number of energy applications ranged from 1-19 (median 6). In 35/41 patients slow pathway ablation could be achieved; in six patients the slow pathway was modulated. In none of the patients permanent high grade AV block was observed. During follow-up (mean 4.1 years) two patients had a recurrent episode of AVNRT after slow pathway modulation. All other patients are still free of AVNRT without medical treatment. CONCLUSION: Selective radiofrequency current ablation/modulation of the slow pathway is a safe and curative treatment of AVNRT in young patients.     

Incidence and clinical significance of inducible atrial tachycardia in patients with atrioventricular nodal reentrant tachycardia

INTRODUCTION: The purpose of this prospective study was to determine the prevalence and clinical significance of inducible atrial tachycardia in patients undergoing slow pathway ablation for AV nodal reentrant tachycardia who did not have clinically documented episodes of atrial tachycardia. METHODS AND RESULTS: Twenty-seven (15%) of 176 consecutive patients who underwent slow pathway ablation for AV nodal reentrant tachycardia were found to have inducible atrial tachycardia with a mean cycle length of 351+/-95 msec. The atrial tachycardia was sustained in 7 (26%) of 27 patients and was isoproterenol dependent in 20 patients (74%). The atrial tachycardia was not ablated or treated with medications, and the patients were followed for 9.7+/-5.8 months. Six (22%) of the 27 patients experienced recurrent palpitations during follow-up. In one patient each, the palpitations were found to be due to sustained atrial tachycardia, nonsustained atrial tachycardia, recurrence of AV nodal reentrant tachycardia, paroxysmal atrial fibrillation, sinus tachycardia, and frequent atrial premature depolarizations. Thus, only 2 (7%) of 27 patients with inducible atrial tachycardia later developed symptoms attributable to atrial tachycardia. CONCLUSION: Atrial tachycardia may be induced by atrial pacing in 15% of patients with AV nodal reentrant tachycardia. Because the vast majority of patients do not experience symptomatic atrial tachycardia during follow-up, treatment for atrial tachycardia should be deferred and limited to the occasional patient who later develops symptomatic atrial tachycardia.     

Transcatheter Modulation of Atrioventricular Nodal Conduction by Radiofrequency Current

A new technique is presented in which atrioventricular (A V) nodal conduction properties can be altered in a controlled way through the application of radiofrequency current. In 13 patients with supraventricular arrhythmias (maximal heart rate 215/min) radiofrequency current was delivered to the A V node via a catheter. Nine patients had atrial fibrillation, three had A V nodal reentrant tachycardia, and one patient had accessory pathway mediated A V tachycardia. Radiofrequency current application in these patients increased AV nodal conduction time and antegrade A V nodal effective refractory period significantly. In three patients radiofrequency current had no effect, and the A V node was ablated with direct current shocks. During a mean follow-up period of 10 ± 3 months, all ten patients in whom radiofrequency current application had been successful were asymptomatic without antiarrhythmic medication. No complications were observed, neither during nor after the procedure.     

Comparison of late results of surgical or radiofrequency catheter modification of the atrioventricular node for atrioventricular nodal reentrant tachycardia.

AIMS: Although arrhythmia surgery and radiofrequency catheter ablation to cure atrioventricular nodal reentrant tachycardia differ in technical concept, the late results of both methods, in terms of elimination of the arrhythmogenic substrate and procedure-related new and different arrhythmias, have never been compared. This constituted the purpose of this prospective follow-up study. METHODS AND RESULTS: Between 1988 and 1992, 26 patients were surgically treated using perinodal dissection or 'skeletonization', and from 1991 up to 1995, 120 patients underwent radiofrequency modification of the atrioventricular node for atrioventricular nodal reentrant tachycardia. The acute success rates of surgery and radiofrequency catheter ablation were 96% and 92%, respectively. Late recurrence, rate in the surgical and radiofrequency catheter ablation groups was 12% and 17%, respectively. Mean follow-up was 53 months in the surgical group and 28 months in the radiofrequency catheter ablation group. The final success rate after repeat intervention was 100% in the surgical group and 98% in the radiofrequency catheter ablation group. Comparison of the initial and recent series of radiofrequency catheter ablated patients showed an increased initial success rate with fewer applications. In the radiofrequency catheter ablation group, a second- or third-degree block developed in three patients (2%), requiring permanent pacing, whereas in the surgical group no complete atrioventricular block was observed. Inappropriate sinus tachycardia needing drug treatment was observed in 13 patients (11%), mostly after fast pathway ablation, but was never observed after surgery. New and different supraventricular tachyarrhythmias arose in 27% of the patients in the surgical group and in 11% of the radiofrequency catheter ablation group, but did not clearly differ. CONCLUSION: This one-institutional follow-up study demonstrated comparable initial and late success rates as well as incidence of new and different supraventricular arrhythmias following arrhythmia surgery and radiofrequency catheter ablation for atrioventricular nodal reentrant tachycardia. Today radiofrequency catheter ablation has replaced arrhythmia surgery for various reasons, but the late arrhythmic side-effects warrant refinement of technique.     

Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia. Evidence for involvement of perinodal myocardium within the reentrant circuit.

BACKGROUND. The circuit of atrioventricular (AV) nodal reentrant tachycardia may include perinodal atrial myocardium. Furthermore, in patients with dual AV nodal pathways, the atrial insertion of the slow pathway is likely to be located near the ostium of the coronary sinus, caudal to the expected location of the AV node. The present study was designed to evaluate the safety and efficacy of selective catheter ablation of the slow pathway using radiofrequency energy applied along the tricuspid annulus near the coronary sinus ostium as definitive therapy for AV nodal reentrant tachycardia. METHODS AND RESULTS. Among 34 consecutive patients who were prospectively enrolled in the study, the slow pathway was selectively ablated in 30, and the fast pathway was ablated in four. Antegrade conduction over the fast pathway remained intact in all 30 patients after successful selective slow pathway ablation. There was no statistically significant change in the atrio-His interval (68.5 +/- 21.8 msec before and 69.6 +/- 23.9 msec after ablation) or AV Wenckebach rate (167 +/- 27 beats per minute before and 178 +/- 50 beats per minute after ablation) after selective ablation of the slow pathway. However, the antegrade effective refractory period of the fast pathway decreased from 348 +/- 94 msec before ablation to 309 +/- 79 msec after selective slow pathway ablation (p = 0.005). Retrograde conduction remained intact in 26 of 30 patients after selective ablation of the slow pathway. The retrograde refractory period of the ventriculo-atrial conduction system was 285 +/- 55 msec before and 280 +/- 52 msec after slow pathway ablation in patients with intact retrograde conduction (p = NS). There were three complications in two patients, including an episode of pulmonary edema and the development of spontaneous AV Wenckebach block during sleep in one patient after slow pathway ablation and the late development of complete AV block in another patient after fast pathway ablation. Over a mean follow-up period of 322 +/- 73 days, AV nodal reentrant tachycardia recurred in three patients, all of whom were successfully treated in a second ablation session. CONCLUSIONS. Radiofrequency ablation of the slow AV pathway is highly effective and is associated with a low rate of complications.     

Catheter ablation for cardiac arrhythmias

The clinical introduction of catheter ablation in 1981 revolutionized the treatment of cardiac arrhythmias. Implementation of radiofrequency as an alternative energy source, with the advantages of higher selectivity and less collateral damage, provided an expansion of catheter ablation therapy. Today the majority of arrhythmias can potentially be cured with catheter ablation therapy. The safety and efficacy of catheter ablation for treatment of AV nodal reentrant tachycardia, accessory pathway arrhythmias, focal atrial tachycardia, atrial flutter and idiopathic ventricular tachycardia, is well established. Catheter ablation for treatment of atrial fibrillation and ventricular tachycardia secondary to structural heart disease, remains an area of active research. In this article we will review the current state of knowledge about the technique, indications, and results of catheter ablation for the treatment of cardiac arrhythmias.     

Role of invasive electrophysiologic testing in the evaluation and management of adult patients with focal junctional tachycardia

Focal junctional tachycardia (FJT) is characterized by a rapid often irregular narrow complex tachycardia with episodes of atrioventricular (AV) dissociation. This uncommon arrhythmia is most likely due to abnormal automaticity or triggered activity. The patients are often quite symptomatic and if left untreated may develop heart failure particularly if their tachycardia is incessant. In patients refractory to medical management, the role of radiofrequency ablation involves either (1) selective ablation of the tachycardia focus while preserving AV conduction or as a last resort (2) AV junction ablation followed by pacemaker implantation. The clinician should first assess whether ventriculoatrial (VA) conduction is present or absent during tachycardia. If present, radiofrequency ablation should be applied at the site of earliest retrograde atrial activation. In the absence of VA conduction and hence an atrial target site, sequential lesions should be applied in the posterior septum (slow pathway region) followed by lesions applied in midseptum and anteroseptum respectively if tachycardia persists. To further minimize the risk of AV nodal block, some authors delivered radiofrequency energy during atrial overdrive pacing to assess AV conduction during ablation. Others recommended mapping the perinodal region and applying radiofrequency ablation at the site where catheter manipulation resulted in tachycardia termination. Using this ablative approach, the risk of AV block is around 5–10%.     

Ice mapping during tachycardia in close proximity to the AV node is safe and offers advantages for transcatheter ablation procedures

BACKGROUND: Ablation during ongoing orthodromic reentry tachycardia (AVRT) and atrioventricular nodal reentry tachycardia (AVNRT) is not recommended using radiofrequency energy when the arrhythmia substrate is located in close proximity to the atrioventricular (AV) node due to a significant risk for inadvertent AV block. The aim of the study is to test the feasibility of ice mapping during tachycardias involving arrhythmia substrate located in close proximity to the AV node. METHODS: This was a single-centre, prospective, randomized study. A total of 65 patients was screened and 30 patients with supraventricular arrhythmias were assigned either to a cryo or RF energy group after diagnosis of AVNRT (17 pts) or AVRT (13 pts) with an anteroseptal accessory pathway. RF ablation was performed using standard ablation techniques. In the cryo group, ice mapping was performed during tachycardia with cooling of the catheter tip temperature to a maximum of -40 degrees C. Ablation was performed only if ice mapping terminated the tachycardia without prolongation of the AV conduction. RESULTS: The overall acute success rate was 84%, and was not different in the cryo and RF groups (85% vs. 82.4%, P = 0.43). Both fluoroscopy and the procedure times were comparable. There was a marked reduction in the mean number of applications in the cryo group [2 (1-6) vs. 7 (1-41), P = 0.002]. In one patient ablation was not attempted in the cryo group because of AV prolongation, and in two patients temporary second-degree AV block was observed in the RF group. After 12 months follow-up the long-term success rate was similar between the two groups. CONCLUSIONS: (I) Ice mapping is a feasible method to determine the exact location of accessory pathways and of the slow pathway during tachycardia. (2) Ice mapping performed during tachycardia causes less ablation lesions without increasing the procedure and fluoroscopy times.